TY - JOUR
T1 - Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?
AU - Kessels, Janneke P. H. M.
AU - Nelemans, Patty J.
AU - Mosterd, Klara
AU - Kelleners-Smeets, Nicole W. J.
AU - Krekels, Gertruud A. M.
AU - Ostertag, Judith U.
PY - 2016
Y1 - 2016
N2 - Photodynamic therapy (PDT) with light emitting diode (LED) illumination is a frequently used treatment modality for actinic keratosis (AK) with excellent cosmetic outcome. A major disadvantage, however, is the high pain score. Pulsed dye laser (PDL) illumination has been suggested, but the long-term efficacy of this treatment is unknown. In this split-face study we prospectively treated 61 patients with AK, with both LED-PDT and PDL-PDT. The mean change in the number of lesions between the end of follow-up and start of therapy was 4.25 (95% confidence interval (95% CI)-5.07; 3.43) for LED-PDT and 3.88 (95% CI 4,76; 2.99) for PDL-PDT, with a non-significant difference (p=0.258) of-0.46 (95% CI -1.28; 0.35). The percentage decrease from baseline in the total number of AK was 55.8% and 47.8%, respectively, at 12-month follow-up. Visual analogue scale pain score was lower after PDL (mean 2.64) compared with LED illumination (mean 6.47). These findings indicate that PDL-PDT is an effective alternative illumination source for AK when pain is a limiting factor for regular LED-PDT.
AB - Photodynamic therapy (PDT) with light emitting diode (LED) illumination is a frequently used treatment modality for actinic keratosis (AK) with excellent cosmetic outcome. A major disadvantage, however, is the high pain score. Pulsed dye laser (PDL) illumination has been suggested, but the long-term efficacy of this treatment is unknown. In this split-face study we prospectively treated 61 patients with AK, with both LED-PDT and PDL-PDT. The mean change in the number of lesions between the end of follow-up and start of therapy was 4.25 (95% confidence interval (95% CI)-5.07; 3.43) for LED-PDT and 3.88 (95% CI 4,76; 2.99) for PDL-PDT, with a non-significant difference (p=0.258) of-0.46 (95% CI -1.28; 0.35). The percentage decrease from baseline in the total number of AK was 55.8% and 47.8%, respectively, at 12-month follow-up. Visual analogue scale pain score was lower after PDL (mean 2.64) compared with LED illumination (mean 6.47). These findings indicate that PDL-PDT is an effective alternative illumination source for AK when pain is a limiting factor for regular LED-PDT.
KW - pulsed dye laser
KW - actinic keratosis
KW - photodynamic therapy
U2 - 10.2340/00015555-2278
DO - 10.2340/00015555-2278
M3 - Article
SN - 0001-5555
VL - 96
SP - 351
EP - 354
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
IS - 3
ER -